The independent source for health policy research, polling, and news.
6,101-6,120 of 112,945 results
The facility in question is in Fosston, Minnesota. Separately, Bloomberg reports on the failed sale of Pennsylvania hospital chain Tower Health's Brandywine hospital. A merger of two New Jersey providers — Saint Peter's Healthcare System and Atlantic Health System — is also in the news.
An AP report draws attention to a rise of marketing unproven cures and treatments, driven by conspiracy theorists and rising social media use against a backdrop of skepticism about traditional health science. Meanwhile, the CDC's new vaccice schedule for kids addresses fears over egg allergies.
They acknowledge though that there are tough headwinds to change abortion law in states with Republican-majority legislatures.
Parents have blamed Meta, TikTok, X, Snap, and Discord for fueling cyberbullying and even their children’s suicides. In an extraordinary moment during his congressional testimony Wednesday, Meta CEO Mark Zuckerberg stood and told parents in the room, "I’m sorry for everything you have all been through." Every CEO stressed that they are parents, too.
Military staff stationed at the base from 1975 to 1985 had a higher chance of developing a number of cancers, CDC data say. Separately, the EPA has OK'd the use of the herbicide paraquat, despite its known links to Parkinson's disease.
Philips ventilators and devices for treating obstructive sleep apnea are linked to 561 reported deaths since 2021. Also in the news: CVS will close 25 MinuteClinic sites in Los Angeles; GSK settled another Zantac lawsuit in California; FDA warns against using some unapproved eyedrops; and more.
Cigna is shedding its troubled Medicare Advantage, Medigap, and Medicare part D plans that cover 3.6 million people. The business will be sold to Health Care Service Corp., a Blue Cross Blue Shield insurer.
Neurimmune, the Swiss company that invented Aduhelm, will regain full rights to it from Biogen. The FDA's accelerated approval of the drug in 2021 was contentious and there has been limited marketplace for and coverage of Aduhelm since.
The Biden administration sent starting offers in Medicare price negotiations with drugmakers for 10 prescription medications that were previously selected. The companies have until March 2 to respond to initial proposals, with other rounds of talks expected through the spring.
Today's early morning highlights from the major news organizations.
Read recent pharmaceutical developments in KFF Health News' Prescription Drug Watch roundup.
Read recent commentaries about pharmaceutical issues.
Editorial writers tackle misinformation, covid, gene therapy, and more.
The new anti-trans law also defines the legal definition of "male" and female" based on a person's genitalia instead of gender identity. Meanwhile, in Florida, trans people can no longer update their driver's licenses to match gender identity — a move not prompted by any new law.
Americans trust nurses even more than doctors, the new 2023 Honesty and Ethics poll found: 78% of Americans taking part in the poll felt nurses kept to "very high" or "high" standards of honesty and ethics. Also in the news: female body dummies for CPR training.
A new study published in the BMJ calls attention to failures in the U.S. regulatory system that contributed to the deaths of thousands of frontline workers during the pandemic. Separate research shows up to 75% of adults have hidden an infectious illness in order to work, travel, or socialize.
In 2022, nearly 8.7% of U.S. births were premature, new data from the National Center for Health Statistics show. Black mothers were nearly twice as likely as white peers to give birth before full term. Also in the news: the VA will expand fertility treatment options to single vets and same-sex couples.
Vertex Pharmaceuticals' new drug works by blocking pain signals before they get to the brain and is expected to avoid some issues that opioid pain drugs cause via addiction. The new drug is sparking debate on how widely it would be used if it wins regulatory approval.
Axios says rising demand for medical care is bringing "good vibes" to the hospital industry's financial outlook, even as health insurers are left nervous. Also in the news: Humana expands its CenterWell care into new markets; Accompany Health launches; digital therapeutics; and more.
The Centers for Medicare and Medicaid Services will pursue so-called outcomes-based agreements that would put discounts or rebates in place on two new expensive gene therapies if they don't deliver promised results for patients with sickle cell disease.
© 2026 KFF